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Abstract Many foods in our diets such as berries, tea, chocolate and wine contain
flavonoids, which are natural components of plants. A substantial body of
evidence supports the role of flavonoids in providing protection against cardio-
metabolic diseases and disorders. Despite the nearly exponential growth in
flavonoid research in the past 20 years, limited progress has been made in
understanding how these dietary components work. Research initially focused on
their antioxidant activity without taking into account their metabolism, which
now appears extensive. This has provided a new research impetus to understand
the biological activity of the flavonoid metabolites. Here, we outline recent
research, which suggests a highly complex interplay between metabolism,
intestinal microflora, the immune system and various tissues of our body.
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Introduction
Phytochemicals are compounds originating from
plants, which are often referred to as ‘foreign chemi-
cals’ (or xenobiotics) because they are not produced
or synthesised by humans. These compounds can be
both toxic/poisonous (such as alkaloids or cyanogenic
glycosides found in seeds, leaves and stems) or benefi-
cial to health (as in the case of dietary flavonoids).
Flavonoids are phytochemicals found in a variety of
fruits, vegetables and processed foods of plant origin
and are reported to promote healthy ageing. Regard-
less of their biological effects, human metabolism is
generally perceived to reduce the reactivity (via detoxi-
fication) or promote more rapid elimination (via
excretion) of these foreign compounds from the body
(Omiecinski et al. 2011). However, it is now becom-
ing clear that this may be an oversimplification and
not the case for all plant chemicals. Growing evidence
suggests that the metabolism of some phytochemicals
may actually increase their biological activity, as is
seemingly the case for flavonoids. In addition to
human-derived metabolism (metabolic conjugation),
recent evidence has revealed that our intestinal bacte-
ria may play an integral role in human metabolism,
adding a further layer of complexity to this story.
Absorption of nutrients and non-nutrients was previ-
ously thought to occur primarily in the upper small
intestine, with the extensive bacterial biomass in our
lower bowel largely associated with breakdown (cata-
bolism) and excretion. Shifting opinion in phytochemi-
cal research is now considering the impact of the
microbiota on human health, as bacterial metabolites
appear to be absorbed and distributed to tissues
throughout the body, having body-wide (or systemic)
activity (Ursell et al. 2014). Further evidence indicates
that phytochemicals, such as flavonoids and other
polyphenols, may not even require absorption to be
biologically active. Emerging evidence suggests that
polyphenols influence the body without ever leaving
the intestine, through interactions with bacteria and
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human immune processes in the gastrointestinal tract,
which have systemic consequences (Anhe^ et al. 2013,
2015).
Complex relationship between diet
and health
While we are beginning to have a greater under-
standing of the complexity of human metabolism, it
is becoming clear that past hypotheses and models
of studying phytochemical bioactivity require refine-
ment. Previously, the common practice was to study
the impact of plant chemicals on cellular activity in
the laboratory (in vitro or ex vivo human cell culture
models), in order to make assumptions regarding
human health. Because most tissues in our bodies are
unlikely to come into contact with appreciable con-
centrations of unmetabolised plant-derived chemicals,
it is conceivable that the assumptions previously
made were inaccurate. Recent findings suggest we
should ‘go back to the drawing board’ and explore
the activity of phytochemical metabolites (human-
and bacterial-derived) as they appear to be the prin-
cipal compounds coming into contact with the cells,
tissues and organs of our bodies (Del Rio et al.
2013; Chen & Sang 2014; Rodriguez-Mateos et al.
2014).
New insights into familiar dietary
constituents
Flavonoids found in a variety of foods in our diets,
including berries, tea, chocolate and wine, appear to
be protective against cardio-metabolic disease (Cas-
sidy et al. 2011; Kay et al. 2012; Hollman 2014;
Rodriguez-Mateos et al. 2014). However, many fla-
vonoids are prone to extensive metabolism and the
effect this has on their biological activity is still
unknown (Hollman 2014; Rodriguez-Mateos et al.
2014). Recent funding from a Biotechnology and Bio-
logical Sciences Research Council (BBSRC) – Diet
and Health Research Industry Club (DRINC) sup-
ported project shed light on the inherent complexity
of flavonoid metabolism (Czank et al. 2013; de Fer-
rars et al. 2014). The study explored the metabolism
and bioavailability of a class of flavonoid called
anthocyanins, which are found in red and purple
foods in the diet, such as berries, wine, and many
red and purple fruits and vegetables. When this work
was first undertaken, the literature suggested that
anthocyanins were poorly bioavailable, with most
studies reporting <1% of consumed anthocyanins
recoverable in blood and urine (Kay 2010; Miller
et al. 2013). At this time, researchers speculated that
the low bioavailability resulted from poor absorption
and chemical instability (Kay 2006; Woodward et al.
2009; Miller et al. 2013). However, no conclusive
evidence was available to account for the disappear-
ance of the remaining 99% of ingested anthocyanins.
The BBSRC-DRINC funded study revealed an
extensive biotransformation of anthocyanins when
researchers characterised absorption, metabolism and
elimination of an isotopically labelled anthocyanin
(500 mg of pure 13C5-cyanidin-3-glucoside) in eight
male participants (Czank et al. 2013; de Ferrars et al.
2014). The analysis revealed a calculated relative
bioavailability (i.e. amount absorbed and found in
blood, urine and breath) of 12%. An extensive diver-
sity of metabolites was identified (>30 unique struc-
tures), including phenolic, hippuric, phenylacetic and
phenylpropenoic acids. These findings support new
avenues of research in order to identify the biological
activity of the identified metabolites, which are likely
to hold the key to understanding how dietary flavo-
noids work within the body to elicit their reported
health effects.
Recent findings from biological activity
studies
Following this new research direction, the metabolites
identified in the previous human trial were screened
for their health effects in established human cell
culture models. As anthocyanins were reported to be
associated with improvements in cardiovascular
health, we explored the activity of the metabolites
using endothelial cell models, as these are the cells
that come into direct contact with our blood and are
involved in blood vessel function. We identified that
the metabolites were not acting in exactly the same
manner as their unmetabolised structures (i.e. antho-
cyanins, as found in plants), having no activity on
mediators of vascular responsiveness such as nitric
oxide (which is known to regulate blood pressure) but
rather acting indirectly through upregulating haem
oxygenase. Haem oxygenase is an enzyme which can
cause the release of carbon monoxide, influence the
synthesis of nitric oxide and modulate anti-inflamma-
tory activity, ultimately influencing our cardiovas-
cular system (vascular tone) (Edwards et al. 2015).
In addition, we explored metabolite activity in vascu-
lar cell models which mimic the initiation of an
inflammatory stress and found that many metabolites
of anthocyanins could reduce the production of
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pro-inflammatory proteins (cytokines and adhesion
molecules) associated with cardiovascular disease pro-
gression (Amin et al. 2015). The data from this pro-
ject suggest anthocyanin metabolites are bioactive and
have the potential to modulate cardiovascular disease
progression by downregulating the expression of pro-
inflammatory proteins which negatively impact cardio-
vascular health.
Similarity across dietary constituents
Anthocyanins are not the only class of dietary flavo-
noid where beneficial health effects are associated with
intake. There are many other classes such as flavones,
flavonols, flavanones and flavan-3-ols, which are
prominent in our diets in tea, citrus, chocolate, wine,
apples, onions etc. (Hooper et al. 2008; Del Rio et al.
2010; van Dam et al. 2013; Rodriguez-Mateos et al.
2014). At the time the above-described studies were
being conducted, numerous studies were reporting that
other classes of flavonoids had almost equally complex
metabolite profiles (Chen & Sang 2014; Rodriguez-
Mateos et al. 2014). As many of these metabolites
were structurally similar, this led us to speculate that
flavonoids may have a common biological activity. We
hypothesised that flavonoids share common biological
activities based on their structural similarities, and
their reported health effects must be the result of mul-
tiple compounds working collectively in the body.
Through a subsequent BBSRC-DRINC funded project,
we tested this hypothesis, by exploring the activity of
flavonoids found in commonly consumed flavonoid-
rich foods (namely, epicatechin, cyanidin, quercetin,
naringenin, peonidin and hesperetin), along with 13 of
their common metabolites. In addition, we also
explored the activity of mixtures of flavonoids and
their metabolites (as 28 unique mixtures), in an
attempt to establish the potential effects of consuming
a diet rich in flavonoids. Here, we employed a screen-
ing model which looked at complementary cell sys-
tems within the vasculature, evaluating mechanisms
associated with vascular reactivity, inflammatory and
antioxidant defence, in human vascular endothelial,
smooth muscle and immune cells (monocytes). Again
we found that the metabolites did not appear to signif-
icantly modulate cellular redox status (cellular antioxi-
dant response), which is a common reported activity
of the unmetabolised parent flavonoids. In fact, there
was limited activity of the metabolites on a number of
markers of vascular responsiveness (eNOS, angioten-
sin-II induced superoxide, NOX) (Edwards et al.
2015). When we created a stress environment, by
using pro-inflammatory molecules (such as TNF-a,
CD40, oxLDL, LPS) as vascular cell stressors, many
metabolites were able to reduce pro-inflammatory
cytokine (such as IL-6 and TNF-a) and cell adhesion
marker (such as VCAM-1) production, which are
involved with the initiation of plaque formation (Amin
et al. 2015; di Gesso et al. 2015). Interestingly, when
we looked at the effect of low levels of metabolites in
combination, reflecting blood profiles following con-
sumption of a flavonoid-rich diet, we still saw activity
on TNF-a reduction in immune cells and HO-1 in vas-
cular smooth muscle cells (for two of the metabolites)
(di Gesso et al. 2015).
Present informing future
From our screening data, it was apparent that, at con-
centrations identified in human studies, the parent/
unmetabolised flavonoids had limited activity, but
metabolites (namely methyl, glucuronide, sulphate
conjugates of protocatechuic acid, vanillic acid and
benzoic acid) were active across many assays. Also,
when these metabolites were treated as mixtures of
compounds, some were often just as active and, in a
few cases, more active than when used in isolation.
These findings together indicate that the biological
activity of flavonoids likely results from the activity of
multiple metabolites acting collectively in the body,
and the activity appears to be achievable following
normal dietary consumption (as we studied concentra-
tions achievable following consumption of 3–5 and
5–7 servings of flavonoid-rich foods). However, from
these studies, the exact cellular mechanisms of action
at these dietary achievable concentrations are difficult
to ascertain, and further research is required to form
an understanding of how these metabolites affect their
target cells and tissues. The evidence provided by these
projects leads us in new research directions, exploring
the mechanisms behind metabolite activity. Ultimately,
this present and future research will inform the design
of forthcoming dietary intervention studies exploring
optimal dietary intakes of flavonoid-rich products,
which will assist regulatory agencies in developing
more targeted dietary guidelines for the promotion of
healthy ageing.
Adding another layer of complexity
to the story
While the activity of dietary flavonoids described
above was in relation to compounds which are
absorbed and found in the bloodstream, a substantial
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proportion of the flavonoids we consume are not
absorbed and thus never enter the bloodstream prior
to excretion (Manach et al. 2005; Del Rio et al. 2013;
Rodriguez-Mateos et al. 2014). You would think that
it was the end of the story for these unabsorbed com-
pounds; however, a new paradigm in polyphenol
research is arising, one which suggests that even com-
pounds in our intestine can have an impact on our
health, without ever being absorbed (Kinross et al.
2011; Ursell et al. 2014). New evidence suggests that
the cells (including bacterial cells) and tissue of our
digestive tract play a major role in inflammation, obe-
sity and associated disease, and this activity is affected
directly by our diets. Progressively more evidence indi-
cates that changes in the population of gut microflora
may be a chief regulator of disease, and that our
gut microbiota affect our metabolism and immune
response. In a recent study, feeding a polyphenol-rich
cranberry extract to mice was shown to protect
against diet-induced obesity, insulin resistance and
intestinal inflammation and the effects were associated
with an increased bacterial population (Akkermansia
spp.) in the gut microbiota (Anhe^ et al. 2015). Further
studies feeding polyphenol-rich berry extracts to
rodents have shown alterations in the regulation of
metabolic pathways implicated in inflammatory
response (Anhe^ et al. 2013). In addition, the polyphe-
nol-enriched diets were shown to increase populations
of beneficial bacterial species (such as Bifidobacteria,
Barnesiella, Oscillibacte). As these effects occur inside
the intestine (i.e. intestinal lumen) and do not require
polyphenol absorption, the evidence indicates that
even unabsorbed polyphenols have influence over
body composition and inflammatory response (Anhe^
et al. 2013, 2015).
General conclusions
Overall, the present evidence suggests that the bioac-
tivity of flavonoids results from low exposure to a
variety of structurally similar metabolites modifying
various inflammation and cellular adhesion pathways.
These studies on metabolism and biological activity
of metabolites mark a new beginning in phytochemi-
cal research and, in this respect, this work is in its
infancy. The research outlined here suggests a highly
complex interplay between foods we eat, metabolism,
microflora, the immune system and various tissues of
our body. As with most new discoveries or para-
digms, we are left with more questions than answers,
making it an exciting time for nutrition and health
research.
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